Cite

    Shao, Y., Xu, K., Zheng, X., Zhou, B., Zhang, X., Wang, L., Sun, Y., Li, D., Chen, T., Wang, J., Yu, S., Sun, L., Xu, X., Dai, S., Gao, H., Ruan, G., Liu, W., Cai, X., Zhu, T., Qi, L., Chen, J., Hu, W., Weng, X., Zhu, Y., Xiang, X., Hu, Z., Li, J., Chen, L., Shao, J., Zheng, S., & Guo, T. (2022). proteomics profiling of colorectal cancer progression identifies PLOD2 as a potential therapeutic target. Cancer communications, 42(2), 164–169. http://access.bl.uk/ark:/81055/vdc_100150592087.0x000004